Mitsubishi to withdraw from fine chemical business
The Pharmaceutical ingredient manufacturing and sales operations will be transferred to API Corporation and food chemical operations will be transferred to Taisho Technos, effective 1 July 2012. API
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.
According to the agreement, Bristol-Myers will fund oncology, immunoscience and structural biology research efforts at Tsinghua University’s School of Life Sciences. Tsinghua University vice president Kejun Kang said